Dulaglutide: A Review in Type 2 Diabetes-Reference-Cited by-同舟云学术

Dulaglutide: A Review in Type 2 Diabetes

Published:2020-01-30 Issue:2 Volume:80 Page:197-208
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Scott Lesley J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-020-01260-9.pdf

Reference58 articles.

1. Shin J-I. Second-line glucose-lowering therapy for type 2 diabetes mellitus. Curr Diab Rep. 2019;19(8):54.

2. International Diabetes Federation. IDF clinical practice recommendations for managing type 2 diabetes in primary care. 2017. https://www.idf.org. Accessed 11 Nov 2019.

3. American Diabetes Association. 10. Cardiovascular disease and risk management: standards of diabetes care. Diabetes Care. 2019;4(Suppl 1):103–23.

4. Buse JB, Wexler DJ, Tsapas A, et al. 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63:221–8.

5. European Medicines Agency. Trulicity (Dulaglutide): EU summary of product characteristics. 2019. https://www.ema.europa.eu/. Accessed 10 Dec 2019.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Very Rare Cause of Markedly Elevated CA 19-9: Glucagon-like Peptide-1 Receptor Agonists;Diabetes & Metabolism;2024-09

2. Correlation between intestinal flora and GLP-1 receptor agonist dulaglutide in type 2 diabetes mellitus treatment—A preliminary longitudinal study;iScience;2024-05

3. Early onset stage III diabetic nephropathy in a child with Prader-Willi syndrome treated with dulaglutide: a case report;Translational Pediatrics;2024-05

4. Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease;Frontiers in Pharmacology;2024-04-24

5. Review on therapeutic potential of peptides: Advancements in synthesis methods, linear and cyclic peptides, and strategies for overcoming challenges;Peptide Science;2024-02